UBS Group’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

UBS Group’s Portfolio LVACW Stock Details LVACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-590	Closed	-$32	–	10329
2023 Q1	$32	Buy	+590	New	+$32	﹤0.01%	9385

UBS Group's LVACW Position: Q2 2023 in Review

UBS Group sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 590 shares — an estimated $32 sold.

UBS Group first reported a position in LVACW in Q1 2023 and held it in 1 quarter. The position peaked at $32 in Q1 2023. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

UBS Group reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
UBS Group sold 590 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $32.
UBS Group first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q1 2023 and held it in 1 quarter.
UBS Group's LAVA Medtech Acquisition Corp. Warrants position peaked at $32 in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.